Lithium Titration Protocol
Start lithium at 300 mg twice daily (or 450 mg twice daily if the patient is younger, clinically stable, and not elderly), titrate to achieve a target serum level of 0.6–0.8 mmol/L for most patients, and monitor lithium levels twice weekly during acute treatment until stabilized. 1, 2
Starting Dose
- Standard initiation: 300 mg twice daily (600 mg/day total) 1
- Higher starting dose option: 450 mg twice daily (900 mg/day total) may be used if the patient is clinically stable and not elderly 1
- FDA-approved acute mania dosing: 600 mg three times daily (1800 mg/day total) for optimal response, though this higher dose is typically reserved for acute mania treatment 2
Target Serum Lithium Levels
The target range depends on clinical indication and patient factors:
- Maintenance therapy (most patients): 0.6–0.8 mmol/L 3
- Acute mania: 1.0–1.5 mEq/L during acute phase 2
- Long-term maintenance: 0.6–1.2 mEq/L 2
- Guideline-recommended therapeutic range: 0.8–1.2 mEq/L 1
Important nuance: Recent evidence suggests that levels >0.8 mmol/L may be poorly tolerated, and adequate efficacy can be achieved at 0.5–0.8 mmol/L, especially when lithium is combined with antipsychotics 3. A 2025 study identified lithium levels >0.5028 mEq/L as the threshold associated with increased hypothyroidism risk 4, though this must be balanced against therapeutic efficacy.
Monitoring Schedule
Acute Phase (Treatment Initiation)
- Serum lithium levels: Twice weekly until the patient is stabilized on a consistent dose and therapeutic level is achieved 2
- Clinical monitoring: Weekly assessment for mood symptoms and early signs of relapse 1
Maintenance Phase (After Stabilization)
- Serum lithium levels: Every 2 months for uncomplicated cases 2, or every 3–6 months per guideline recommendations 1
- Renal function (BUN, creatinine): Every 3–6 months 1
- Thyroid function (TSH, free T4): Every 3–6 months 1
Timing of Blood Draw
- Standard timing: Draw blood 12 hours after the last dose when lithium concentrations are relatively stable (8–12 hours post-dose) 2, 5
- For once-daily dosing: The 24-hour level should serve as the control value 5, though 12-hour timing remains the gold standard for comparison with published literature 6
Dose Adjustments
- Titration strategy: Adjust doses based on serum levels and clinical tolerability 1
- Typical maintenance doses by age:
- Elderly patients: Often require reduced dosages and may exhibit toxicity at levels ordinarily tolerated by younger patients 2
Baseline Laboratory Assessment
Before initiating lithium, obtain: 1
- Complete blood count
- Thyroid function tests (TSH and free T4)
- Urinalysis
- Blood urea nitrogen and creatinine
- Serum calcium
- Pregnancy test (if applicable)
Critical Safety Considerations
Toxicity Thresholds
- Toxic range: ≥1.5 mEq/L represents the lower limit of risk for intoxication 7
- Patients sensitive to lithium: May exhibit toxic signs at 1.0–1.5 mEq/L 2
- Never rely solely on serum levels: Accurate evaluation requires both clinical assessment and laboratory analysis 2
Special Populations Requiring Lower Target Levels (0.5–0.6 mmol/L)
- Patients ≥50 years old 3
- Those with diabetes insipidus, renal impairment, or thyroid dysfunction 3
- Patients taking diuretics, ACE inhibitors, or NSAIDs/COX-2 inhibitors 3
- Prophylaxis of bipolar depression or management of acute unipolar depression 3
Common Pitfalls to Avoid
- Abrupt discontinuation: Carries high risk of mood relapse; always taper gradually if discontinuing 1
- Inadequate monitoring frequency: Missing the twice-weekly checks during acute phase can lead to under- or over-dosing 2
- Ignoring renal function changes: Renal insufficiency dramatically reduces lithium clearance and is considered a contraindication, especially with sodium restriction 5
- Pregnancy considerations: Lithium clearance increases 30–50% during the last months of pregnancy due to increased glomerular filtration rate 5